These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 18243718

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma.
    Lai CH, Chang NW, Lin CF, Lin CD, Lin YJ, Wan L, Sheu JJ, Chen SY, Huang YP, Sing YT, Tao TW, Lai CK, Tsai MH, Chan HL, Jou YJ, Lin CW.
    Clin Chim Acta; 2010 Jul 04; 411(13-14):984-91. PubMed ID: 20359475
    [Abstract] [Full Text] [Related]

  • 43. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy.
    Hardt PD, Ewald N.
    Expert Rev Mol Diagn; 2008 Sep 04; 8(5):579-85. PubMed ID: 18785806
    [Abstract] [Full Text] [Related]

  • 44. Serum tumour M2-pyruvate kinase as a biomarker for diagnosis and prognosis of early-stage non-small cell lung cancer.
    Xu C, Liu W, Li L, Wang Y, Yuan Q.
    J Cell Mol Med; 2021 Aug 04; 25(15):7335-7341. PubMed ID: 34255923
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
    Faustino SE, Oliveira DT, Nonogaki S, Landman G, Carvalho AL, Kowalski LP.
    Int J Oral Maxillofac Surg; 2008 Apr 04; 37(4):372-8. PubMed ID: 18295452
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility.
    Weng LP, Wu CC, Hsu BL, Chi LM, Liang Y, Tseng CP, Hsieh LL, Yu JS.
    J Proteome Res; 2008 Sep 04; 7(9):3765-75. PubMed ID: 18646789
    [Abstract] [Full Text] [Related]

  • 50. Serum circulating human mRNA profiling and its utility for oral cancer detection.
    Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, Abemayor E, Wong DT.
    J Clin Oncol; 2006 Apr 10; 24(11):1754-60. PubMed ID: 16505414
    [Abstract] [Full Text] [Related]

  • 51. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
    Novotný I, Dítĕ P, Dastych M, Záková A, Trna J, Novotná H, Nechutová H.
    Hepatogastroenterology; 2008 Apr 10; 55(85):1475-7. PubMed ID: 18795715
    [Abstract] [Full Text] [Related]

  • 52. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.
    Head Neck; 2009 Aug 10; 31(8):1039-48. PubMed ID: 19340865
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
    Fenske W, Völker HU, Adam P, Hahner S, Johanssen S, Wortmann S, Schmidt M, Morcos M, Müller-Hermelink HK, Allolio B, Fassnacht M.
    Endocr Relat Cancer; 2009 Sep 10; 16(3):919-28. PubMed ID: 19465749
    [Abstract] [Full Text] [Related]

  • 55. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.
    Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R.
    Crit Rev Oncog; 1992 Sep 10; 3(1-2):91-115. PubMed ID: 1532331
    [Abstract] [Full Text] [Related]

  • 56. Tu-M2-PK in the blood of testicular and cubital veins in men with testicular cancer.
    Pottek T, Müller M, Blum T, Hartmann M.
    Anticancer Res; 2000 Sep 10; 20(6D):5029-33. PubMed ID: 11326662
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Results of esophagogastroduodenoscopy in patients with oral squamous cell carcinoma--value of endoscopic screening: 10-year experience.
    Kesting MR, Schurr C, Robitzky L, Steinstraesser L, Nieberler M, Baurecht H, Wolff KD, Loeffelbein DJ, Mücke T.
    J Oral Maxillofac Surg; 2009 Aug 10; 67(8):1649-55. PubMed ID: 19615577
    [Abstract] [Full Text] [Related]

  • 60. [M2-type pyruvate kinase in the diagnosis of hepatocarcinoma--a pilot study].
    Liu JB.
    Zhonghua Zhong Liu Za Zhi; 1990 May 10; 12(3):166-9. PubMed ID: 2174328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.